SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-13-115246
Filing Date
2013-03-19
Accepted
2013-03-19 16:47:05
Documents
9
Period of Report
2013-05-08
Effectiveness Date
2013-03-19

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT d499279ddef14a.htm DEF 14A 1542361
2 GRAPHIC g499279g04a84.jpg GRAPHIC 26871
3 GRAPHIC g499279g10b29.jpg GRAPHIC 25906
4 GRAPHIC g499279g65e37.jpg GRAPHIC 8181
5 GRAPHIC g499279g77p44.jpg GRAPHIC 16223
6 GRAPHIC g499279g87i03.jpg GRAPHIC 11709
7 GRAPHIC g499279g89y23.jpg GRAPHIC 8010
8 GRAPHIC g499279pc_pg1.jpg GRAPHIC 217376
9 GRAPHIC g499279pc_pg2.jpg GRAPHIC 100773
  Complete submission text file 0001193125-13-115246.txt   2116414
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES INC (Filer) CIK: 0000882095 (see all company filings)

IRS No.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-19731 | Film No.: 13702385
SIC: 2836 Biological Products, (No Diagnostic Substances)